The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian b-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human b-globin locus, consisting of the linked embryonic (e), fetal (c) and adult (b) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human c-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human c-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human c-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of b-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.
The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian b-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human b-globin locus, consisting of the linked embryonic (e), fetal (c) and adult (b) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human c-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human c-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human c-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of b-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.
The extent to which changes in cis-regulatory elements or the transacting environment account for differences in gene expression in closely related species is the subject of debate 1, 2 . Some studies suggest that changes in cis-regulatory elements are largely responsible for many interspecies differences in gene expression 3, 4 . The contribution of alterations in the trans-acting milieu is less established. With their temporal switches of globin expression, mammalian b-globin loci serve as a model for developmental gene regulation 5 . To study the regulation of human cis-elements in a mouse trans-acting environment, we used human b-globin locus transgenic mice (b-locus mice). The regulation of the human b-globin locus has been widely studied using such mouse models [6] [7] [8] . It is generally accepted that these mice provide a valid system for evaluating human developmental globin gene regulation, although some differences have been noted between humans and these mice. For example, the onset of c-globin expression occurs during the embryonic, yolk sac stage of erythropoiesis in the mouse, whereas high-level expression of this gene occurs during the fetal liver stage in man. Moreover, the switch from c-globin to adult b-globin occurs during early fetal liver erythropoiesis in these mice [6] [7] [8] , whereas it occurs around the time of birth in humans 9 . Furthermore, differences have been noted in the capacity of the mice to respond to fetal haemoglobin (HbF)-eliciting responses that are active in humans 10, 11 . We began by evaluating whether these mice respond to stimuli that consistently increase the level of HbF in humans 12 . We found that these mice have much lower basal levels of c-globin expression than adult humans, and fail to respond to stimuli that result in increased levels of HbF in humans ( Supplementary Fig. 1 ). Also, in a model of juvenile myelomonocytic leukaemia created in these mice, no increase in c-globin levels was observed, in contrast to the high levels of c-globin seen in humans with this syndrome 13 .
Human fetal globin genes behave as mouse embryonic genes
To pursue the underlying basis of these species differences, we reassessed the ontogeny of human c-globin expression during mouse development. First we isolated circulating blood from embryos at a time when c-globin expression is observed (embryonic day (E)13.5) [6] [7] [8] . Using differences in cell size that permit the separation of circulating primitive and definitive lineage cells using flow cytometry 14, 15 , we enriched the erythroid cells in blood from E13.5 b-locus mice (Fig. 1a) . As anticipated, the expression of the mouse embryonic gene ey globin (Hbb-y)-a gene confined to the primitive erythroid lineage along with mouse bh1 globin (Hbb-bh1) 14, 15 -was enriched (approximately fivefold) in the primitive population relative to the definitive population (Fig. 1b) . Consistent with this distribution, human embryonic e-globin (HBE, also known as HBE1) transcripts were similarly enriched in the primitive population (Fig. 1b) . Surprisingly, no difference was observed between the relative enrichment of the embryonic genes and the degree of enrichment of human c-globin transcripts in the primitive erythroid population compared to the definitive cells (Fig. 1b) . This finding indicates that the human c-globin genes are not robustly expressed in early definitive erythroid cells in b-locus mice.
We then used immunohistochemistry (IHC) of c-globin in E13.5 embryos to examine its cellular distribution. IHC of human fetal liver showed positive labelling of all erythroblasts (Fig. 1c) . In contrast, most of the erythroblasts present in the murine fetal liver of b-locus mice failed to stain for c-globin. We observed occasional large nucleated, megaloblastic cells in fetal liver positive for c-globin (Fig. 1d, e) . Morphologically these cells resemble primitive cells that continue to circulate in substantial numbers during this period of gestation 5 . Consistent with this interpretation, the numerous c-globin-positive cells seen in the circulation were all megaloblastic primitive cells, whereas enucleate, smaller definitive cells were uniformly negative (Fig. 1e, f) . To generalize these findings, we performed similar immunohistochemical staining in other independently derived lines of b-locus mice (Fig. 1g, h ) 8 . In all lines, c-globin expression (as indicated by positive IHC) was confined to circulating megaloblastic cells that were infrequent in fetal liver parenchyma. Because similar observations have been made in independently derived b-locus mice, our findings demonstrate a characteristic feature of b-locus mice.
Divergent behaviour of human b-globin loci in mice To gain further insight at the single-cell level, we used primary transcript RNA fluorescence in situ hybridization (PT-FISH) to examine the relative expression of the endogenous mouse and human globin genes at different stages of ontogeny 16, 17 . First, we examined the relative expression of human c-and b-globin (with murine a-globin as a control) in E11.5 primitive erythroid cells from two independent transgenic lines (A20 and A85). Consistent with previous analyses demonstrating high-level expression of c-globin at the primitive erythroid stage in b-locus mice, we noted relatively high expression of c-globin by PT-FISH, with low or absent expression of human b-globin (Fig. 2a, b) . Among circulating primitive cells from a later stage of development (E13.5) a similar pattern was observed, although more human b-globin expression was seen and an overall reduction in the percentage of cells with a PT-FISH signal (using the murine a-globin control) was noted, with only a fraction of the cells (,onethird) showing transcriptionally active loci at a single time point (Fig. 2a, b) . Examples of the cells used in this analysis are shown ( Fig. 2e-g ). An interesting observation made with concomitant PT-FISH analysis of human c-and b-globin is the extent of cotranscription, which represents the concomitant presence of two primary transcript signals in the same gene locus (Supplementary Fig. 2 and Supplementary Information).
Comparison of mouse embryonic ey globin with c-globin showed similar expression levels of the mouse embryonic gene with the human c-globin in circulating primitive cells from E13.5 ( d, h, i). This finding indicates that the expression of the human c-globin genes parallels that of the mouse embryonic b-like genes in the mouse trans-acting environment. Fetal liver cells from E13.5 were analysed in a similar manner, by examining the expression of mouse ey and human c-globin by PT-FISH in these cells. Only a low percentage of cells showed staining for either ey or c-globin (Fig. 2c,  d ), compared with robust transcription of human b-globin at the same stage (Fig. 2a, b) . Consistent with previous developmental analyses in mice 14, 17 , cells positive for mouse ey represent circulating primitive cells present in the mouse fetal liver. The cells that are positive for human c-globin expression are also likely to be primitive erythroid cells, and it is important to recognize that in these cells only a fraction (,one-third) of loci are active at any single time point, thereby limiting the degree of concomitant expression seen. Of note, 45% and 54% (in the A85 and A20 lines, respectively) of the primitive cells from E13.5 with c-globin transcript showed expression of ey globin, supporting the notion that c-globin is treated as an embryonic gene in the mouse trans-acting environment. Interestingly, an early analysis of very low expressing transgenes lacking critical locus region regulatory sequences had suggested that c-globin indeed behaved as an embryonic gene, as we have shown for mice containing the entire robustly expressed human b-locus 18 .
BCL11A restricts mouse embryonic b-like globin expression
From these results we conclude that the homologous mouse erythroid trans-acting environment differs from that of the human, presumably with respect to the composition or regulation of critical transcriptional regulators. We have recently shown that the gene BCL11A, which contains genetic variants that affect HbF levels in humans [19] [20] [21] [22] , encodes a developmental-stage-specific repressor of the human c-globin genes 23 . Our previous findings were confined to an analysis of human erythroid cells, in which we found that fulllength forms of BCL11A were expressed robustly in adult bone marrow erythroblasts, at substantially lower levels in fetal liver, and were absent in primitive erythroblasts. Moreover, shorter variant forms of BCL11A are expressed in human primitive and fetal liver erythroblasts, both of which express c-globin. To investigate potential species differences in BCL11A protein expression, we examined stagematched populations of mouse and human erythroid cells that were subjected to fluorescence-activated cell sorting (FACS). Remarkably, comparison of BCL11A expression in mouse and human samples shows notable differences (Fig. 3a and Supplementary Fig. 3 ). First, BCL11A protein and RNA transcripts are absent in primitive erythroid cells of mice. Second, full-length BCL11A forms are expressed at similar levels in definitive erythroid cells of both mouse fetal liver and bone marrow, whereas no shorter variant forms could be identified in mice (Fig. 3a) . These results highlight important interspecies differences that could potentially have a role in mediating divergent globin gene regulation. A model on the basis of our findings of the developmental expression of the b-like globin genes in humans, mice and b-locus mice is shown, along with a summary of BCL11A expression in these two species (Fig. 3b) .
We have demonstrated that the expression of the human c-globin genes strictly parallels that of the mouse embryonic genes, ey and bh1, in the context of the mouse trans-acting environment. Moreover, the pattern of BCL11A expression suggests a role throughout definitive erythropoiesis in mice, as opposed to its predominant role after birth in humans. Thus, we propose that changes in BCL11A expression may be responsible, at least in part, for the observed interspecies divergent expression of b-like globin genes. To test directly a potential role for BCL11A in silencing the endogenous embryonic genes in the definitive erythroid lineage, we examined BCL11A knockout mice. As described previously 24 
, Bcl11a
2/2 mice die in the perinatal period from unknown causes. We examined Bcl11a 2/2 mice at E14.5 and E18.5 during gestation when robust definitive erythropoiesis is taking place in the fetal liver ( Supplementary Fig. 4) . By phenotypic and morphological approaches 25, 26 , erythropoiesis appeared ostensibly normal in these embryos (Fig. 4a and Supplementary Figs 5-7) . We then assessed expression of the mouse globin genes. In strong support of our hypothesis, we observed that silencing of the expression of mouse embryonic globin genes fails to occur in E14.5 and E18.5 fetal liver erythroid cells (Fig. 4b-e and Supplementary Fig. 8 ). Restriction of embryonic globin expression to the primitive lineage is lost. Expression of the ey and bh1 globin genes was upregulated by 70-and 350-fold, respectively, at E14.5 (Fig. 4b) . Together, these embryonic globin genes account for 50% of the total b-like globin genes at this stage, compared with 0.4% in the controls. At E18.5, whereas the contribution of their transcripts to total b-like globin transcripts was reduced, ey and bh1 globin transcripts were increased 23 ) are reduced in cell populations that express high levels of c-globin, including primitive and fetal liver cells 23 . Furthermore, short variant forms are present at these earlier developmental stages. All human cells were sorted for CD235 and CD71 expression. In contrast, in murine cells, full-length BCL11A protein expression is evident in all definitive progenitor populations, including sorted stage-matched E13.5 fetal liver and bone marrow erythroid cells (all populations were sorted for TER119 1 (also known as LY76) and CD71 1 (also known as TFRC)). No expression of BCL11A in murine primitive cell populations was detected. b, This model summarizes the ontogeny of b-like globin gene regulation in humans, mice and b-locus mice 5, 9 . The ontogeny of mammalian erythropoiesis and progenitor populations is shown at the top. Progenitor populations, including primitive erythroid populations (EryP-CFC), definitive haematopoietic stem cells (HSC), and definitive erythroid burst-forming unit cells (BFU-E) are depicted. The aorto-gonado-mesonephros (AGM) and the placenta are sites of definitive haematopoiesis. The patterns of b-like globin and BCL11A expression seen in the two species are shown below.
2,600-and 7,600-fold compared to controls (Fig. 4c) . To determine the cellular distribution of the mouse embryonic globins, we performed IHC. Using this approach we found that ey and bh1 globins were robustly expressed in definitive erythroid cells (Fig. 4d, e and Supplementary Fig. 9 ), whereas normally these embryonic globins are confined to the primitive erythroid lineage 5 (Fig. 3b) .
Silencing of human c-globin expression depends on BCL11A
We then examined the consequence of BCL11A loss on the regulation of human globin genes in the b-locus mice. By introducing the b-locus transgene into the knockout environment, we found that in the absence of BCL11A, developmental silencing of the c-globin genes is markedly impaired in the definitive erythroid lineage ( Fig. 4f and Supplementary  Fig. 10 ). In Bcl11a
, Bcl11a 1/2 and littermate control mice, c-globin RNA comprised 76%, 20% and 0.24% of total b-like globin gene RNA at E18.5, respectively ( Fig. 4f and Supplementary Fig. 10 ). Relaxation of c-globin gene silencing in Bcl11a 1/2 heterozygotes is consistent with the genetic association of BCL11A and HbF levels, and extends our previous observations using knockdown approaches in human cells 23 that together point to BCL11A as a quantitative regulator of c-globin expression. The failure of c-globin gene silencing in the face of otherwise ostensibly normal erythropoiesis provides compelling evidence that BCL11A is an important regulator of the globin switches in mouse and human ontogeny.
Concluding remarks
Taken together, our findings demonstrate how changes in the expression of a single trans-acting factor over the course of evolution may lead to altered developmental gene expression. We have shown that cis-elements in the human b-globin locus are insufficient to recapitulate proper developmental regulation in a mouse context. Previously it has been postulated that the evolution of b-like globin gene expression is largely mediated through changes in cis-elements 27 . Our findings argue persuasively that changes in trans-acting factors may exert notable effects on gene switching during development. BCL11A acts to silence the embryonic genes in mouse definitive erythroid cells, in contrast to its role in humans where it acts to silence c-globin expression after birth. Moreover, we show that BCL11A is a powerful regulator of the species-divergent globin switches by demonstrating that the c-globin gene escapes proper developmental silencing in a mouse trans-acting Bcl11a 2/2 environment. Our findings suggest a model in which one (or more) trans-acting silencers of the embryonic globin genes, initially expressed throughout definitive erythropoiesis, have been altered during primate evolution, such that their expression is shifted to a later phase of definitive erythropoiesis, allowing for the evolution of a unique fetal haemoglobin expression stage. We have shown here that BCL11A represents one of the major factors regulating this switch. These findings allow for simplification of molecular models accounting for this critical developmental transition. This work provides not only unique insights into how alterations in gene expression occur in the course of evolution, but also reveals further mechanistic clues to the clinically important fetal-to-adult haemoglobin switch in humans. fl/1 controls, n 5 4 for Bcl11a 2/2 mutants). P . 0.1, using a two-sided t-test for all gated populations analysed. b, The expression of the embryonic globins is shown as a percentage of total mouse b-like globins for control mice (fl/1), Bcl11a heterozygous (1/2), and null mice (2/2) at E14.5 (n 5 10, 14 and 11, respectively). c, The expression of the embryonic globins is shown as a percentage of the total mouse b-like globins at E18.5 (n 5 9, 9 and 7, respectively). d, IHC was performed on E14.5 fetal livers from Bcl11a fl/1 and Bcl11a 2/2 animals for the embryonic globin ey. Representative sections at 340 magnification with a 310 objective lens are shown. e, Similar IHC staining was performed for bh1 globin. In both cases robust expression is seen in the scattered erythroblasts of the fetal liver in 
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1/2 and Bcl11a 2/2 animals, respectively) and E18.5 (n 5 4, 7 and 4). All c-and b-globin levels for the different genotypes are significantly different (P , 1 3 10
25
, two-sided t-test). All data are plotted as the mean 6 s.d. of the measurement.
Research Center. The analysis of adult and developmental haematopoiesis/erythropoiesis was performed using FACS-based phenotypic and morphological approaches as described 25, 26 . Quantitative PCR and western blotting were carried out as described 23, 25 . RNA primary transcript fluorescence in situ hybridization was performed with some modification of published protocols 16, 17 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
